Site Editors

Robert I. Haddad, MD

Lori J. Wirth, MD

Advertisement

Advertisement

Videos

Giuseppe Curigliano, MD, PhD, on NSCLC and Thyroid Cancer: Treatment With a Selective RET Inhibitor

Medical Literature

Differentiated Thyroid Cancer and Acromegaly: More Aggressive Evolution?

News

Surgical Guidelines for Low-Risk Differentiated Thyroid Cancer by Tumor Size

News

Effect of In Utero Exposure to Thyroid Cancer on Risk of Disease in Offspring

News

Lymph Node Yield Threshold in Lateral Neck Dissection for Papillary Thyroid Carcinoma

Medical Literature

From Lenvatinib to Sorafenib to Reduce Nephrotoxicity in Thyroid Cancer: Case Study

News

IL1RN Expression: Potential Diagnostic and Prognostic Biomarker for Papillary Thyroid Carcinoma?

Lori J. Wirth, MD, on RET-Altered Thyroid Cancer: Results From a Study on Selpercatinib

The JNCCN Spotlight

View More

Advertisement

JNCCN Spotlights

Dabrafenib + Trametinib (Anaplastic Thyroid Cancer)

Selpercatinib (Retevmo™)

View More

More

News

Surgical Guidelines for Low-Risk Differentiated Thyroid Cancer by Tumor Size

Pralsetinib Granted FDA Approval in Treatment of RET-Altered Thyroid Cancers

Diagnosis of Indeterminate Thyroid Nodules: Comparison of Current Molecular Testing Techniques

Potential Cardiovascular Risks of Thyroid Cancer Therapy and Hyperthyroidism

Surgical Management of Cervical Spine Metastases From Differentiated Thyroid Cancers

Effect of In Utero Exposure to Thyroid Cancer on Risk of Disease in Offspring

ESMO Asia 2020: Anlotinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma

IL1RN Expression: Potential Diagnostic and Prognostic Biomarker for Papillary Thyroid Carcinoma?

View More

Advertisement

Published

Medical Literature

Using Carbon Nanoparticles to Map Lateral Neck Lymph Nodes in Papillary Thyroid Cancer

Total Versus Partial Thyroidectomy for Early-Stage Papillary Thyroid Cancer

Use of Opioids in Patients With Thyroid Cancer After Extensive Neck Dissection

Using AI to Determine the Genetic Risk of Thyroid Nodules

View More

Ongoing

CE Activities

Differentiated thyroid cancer (DTC): therapeutic updates and optimizing treatment

A Unique Approach to Assessing the Risk of Indeterminate Thyroid Nodules

Current and Emerging Treatment Options for Lung Cancer and Head & Neck Carcinoma

Is Radioiodine Tx Overused in Low-Risk Thyroid Cancer?

View More

Available

Clinical Trials

Memorial Sloan Kettering Memorial Center

Samuel Oschin Comprehensive Cancer Center

Yale Cancer Center

University of Michigan Rogel Cancer Center

View More

Resources

For Your Patients

ThyCa: Thyroid Cancer Survivors' Association, Inc.

American Thyroid Association

Rogel Cancer Center Thyroid Cancer Patient Resources

Light of Life Foundation

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2021 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.